 |
 |

A Correction
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
In their article, Tohen et al1 attribute
to me the suggestion that the benefits of placebo have similarities with the
benefits of psychotherapy; they then quote me as saying that both provide
"expectation of improvement, support, and mobilization of hope."
Although I heartily endorse that suggestion, it is not mine. As I make
clear in the article that they cite,2 Jerome
Frank made that suggestion.3 Of less concern
to me, the statement "quoted" from my article,2
which I also endorse, is not actually in there.
Walter A. Brown, MD
Brown Medical School Tufts University School of Medicine 108 Driftwood Dr Tiverton, RI 02878
1. Tohen M, Jacobs TG, Grundy SL, McElroy SL, Banov MC, Janicak PG, Sanger T, Risser R, Zhang F, Toma V, Francis J, Tollefson GD, Breier A for the Olanzapine HGGW Study Group. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled
study. Arch Gen Psychiatry. 2000;47:841-849.
2. Brown WA. Placebo as a treatment for depression. Neuropsychopharmacology. 1994;10:265-269.
ISI
| PUBMED
3. Frank JD, Frank JB. Persuasion and Healing: A Comparative Study of Psychotherapy. Baltimore, Md: The Johns Hopkins University Press; 1991.
In reply
We thank Dr Brown for pointing out that in our article,1
we incorrectly attributed the suggestion that the benefits of placebo have
similarities with the benefits of psychotherapy to Dr Brown, when it should
really be attributed to Dr Frank.2
Mauricio Tohen, MD
Lilly Research . . . [Full Text of this Article]
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Diet (n-3) Polyunsaturated Fatty Acid Content and Parity Interact to Alter Maternal Rat Brain Phospholipid Fatty Acid Composition
Levant et al.
J. Nutr. 2006;136:2236-2242.
ABSTRACT
| FULL TEXT
Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study
FRANGOU et al.
Br. J. Psychiatry 2006;188:46-50.
ABSTRACT
| FULL TEXT
A Dose-Ranging Study of the Effects of Ethyl-Eicosapentaenoate in Patients With Ongoing Depression Despite Apparently Adequate Treatment With Standard Drugs
Peet and Horrobin
Arch Gen Psychiatry 2002;59:913-919.
ABSTRACT
| FULL TEXT
|